10 years is not a long period of time for drug development and health research, but the COVID-19 pandemic has nevertheless shown that certain conditions can be powerful accelerators that spur development and change the world.
Therefore, the French newspaper Le Monde – on the occasion of the tenth anniversary of its weekly “Science and Medicine” supplement – conducted interviews with a group of medical specialists, each according to his field, to discuss the transformations during the next decade, to make it a reference to return to in 2031 to measure The difference between these predictions and reality.
In these interviews by Sandrine Capo, Pascal Santi, Florence Rosier, and Nathaniel Herzberg, Clement Goehrs, MD and co-founder of Synapse Medicine, sees personalized medicine and individualized therapies and monitoring, tailored to individual patient characteristics, become the routine course of treatment. future.
Goehrs believed that the first reason for this is the spread of chronic diseases and the complexity of medication methods, as shown by French statistics that say that 30-40% of the elderly take at least 10 different medicines per day. The second reason is that artificial intelligence today provides the means to learn a lot of health information about an individual. The third is pharmaceutical companies’ massive investment in personalized medicine approaches that began in areas such as cancer science.
These matters – according to the newspaper – are good news for patients because they will become partners in their treatments, while doctors will need more help in making their decisions, and their profession will be closer to managing systems, as is the case of aircraft navigators, knowing that giant digital companies will be the first controller of these systems. .
For his part, Professor Lionel Naccache, a neurologist at the Petit-Salpetriere Hospital and a researcher at the Brain Institute, says that he can imagine a range of developments in the field of neurology, including that cooperation between neurologists and artificial intelligence specialists can provide digital tools that help the doctor in collecting, organizing and analyzing Specific multimedia data about the patient, which is useful in diagnosis and follow-up for neurological patients.
Niqash imagines that the establishment of “brain emergency centers” would combine skills within the same team, which would revolutionize practices, as the patient would be received in a place that brings together all the specialties related to neurological diseases, and that telemedicine – which currently exists – will witness a remarkable development, especially For diseases accompanied by acute temporary crises such as epilepsy.
For his part, psychiatrist David Gurion expects that by 2030 the face of psychiatry will change, especially with regard to big data, sub-specialties, telemedicine, the shortage of psychiatrists and the family, and the increasing demand, as will a merger between neuroscience and humanities, pharmacogenetics and electroencephalography. and neuromodulation.
This specialist imagines how a psychological consultation will play in the future, pointing to the great role that artificial intelligence will play in that consultation, describing in detail the stages of this consultation in which the robot plays a key role, without neglecting the presence of real doctors for emotional and psychological support.
Professor Lawrence Zetvogel of the Gustave Rossi Institute predicts a major advance in the field of oncology, especially with regard to diagnostic tools, imagining that it will rely on data collected from imaging, genetics, metabolism, immunology and microbiology, for superior accuracy.
Thanks to the advent of tele-consultation, the systematic follow-up of side effects of patients’ treatments will develop outside hospitals via mobile applications, and increased attention will be given to prevention through improving the lifestyles of patients at risk.
In the field of prevention, Xavier Goffin, a specialist in cardiology and epidemiology and director of the Center for Sudden Death Experience in Paris, believes that prevention is the most effective, but identifying people at risk using classic prediction models that include about 40 variables, it turned out that it is not enough at the present time.
This specialist notes that the use of artificial intelligence and machine learning has recently enabled them to identify the variables that can predict the probability of sudden death in its time, with a reliability of up to 90% out of 10,000 variables, indicating that this development will lead from a medical point of view to upset the scales of the usual method. in diagnosing the disease, so that it becomes possible to prevent complications before making an accurate diagnosis.
Finally, he believes that it is possible in the future to conduct a large-scale examination of the risks of vascular problems, by using the Medicare databases, and then contacting people classified as at risk, for a full cardiovascular examination, to determine the most appropriate prevention for each case.
deterrent measures against alcohol and tobacco
For his part, warns Devi Sridhar, Professor of Public Health at the University of Edinburgh, that failure to take deterrent measures against alcohol and tobacco use, obesity and lack of physical activity, will lead to the collapse of health systems under the pressure of the current growth of chronic diseases.
This professor says that “what I expect in the next decade is a social turning point in the field of medicine, with the focus shifting to maintaining health rather than focusing on how to treat people,” which requires a change in nutrition and building cities, noting that these things have been ignored for a long time. .
This doctor concluded that the Covid-19 epidemic showed the world the weakness of its health systems, calling for a strategy based on focusing on maintaining health, expecting that this is indeed possible.